Aprotinin in cardiac surgery - re-evaluation of the risks?

被引：0
作者：
Vanek, T. [1 ]
Hlavicka, J. [1 ]
Budera, P. [1 ]
机构：
[1] Kardiochirurg Klin 3 LF UK, Srobarova 50, Prague 10034 10, Czech Republic
来源：
ANESTEZIOLOGIE A INTENZIVNI MEDICINA | 2016年 / 27卷 / 05期
关键词：
cardiac surgery; fibrinolysis; fibrinolytic inhibitors; aprotinin;
D O I：
暂无
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
The article describes the history of introducing aprotinin into cardio-surgical clinical practice and deals with the circumstances based on the results of the BART study leading to its withdrawal from the global pharmaceutical market and with its recent re-authorization in some countries.
引用
收藏
页码：284 / 288
页数：5
相关论文
共 50 条
  • [31] Aprotinin does not impair renal haemodynamics and function after cardiac surgery
    Schweizer, A
    Höhn, L
    Morel, DR
    Kalangos, A
    Licker, M
    BRITISH JOURNAL OF ANAESTHESIA, 2000, 84 (01) : 16 - 22
  • [32] Risks of Anemia in Cardiac Surgery Patients
    Lobel, Gregg P.
    Javidroozi, Mazyar
    Shander, Aryeh
    SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2015, 19 (04) : 288 - 292
  • [33] Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL
    Wagener, Gebhard
    Gubitosa, Gina
    Wang, Shuang
    Borregaard, Niels
    Kim, Mihwa
    Lee, H. Thomas
    AMERICAN JOURNAL OF NEPHROLOGY, 2008, 28 (04) : 576 - 582
  • [34] Fibrinolytic activity and bleeding after cardiac surgery with cardiopulmonary bypass and low-dose aprotinin therapy
    Kuepper, F
    Dangas, G
    Mueller-Chorus, A
    Kulka, PM
    Zenz, M
    Wiebalck, A
    BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (02) : 147 - 153
  • [35] Submassive Pulmonary Embolism: A Re-evaluation of Hemodynamic Instability
    Obi, Megan
    Packer, Clifford D.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (05)
  • [36] Early Postoperative Outcomes and Blood Product Utilization in Adult Cardiac Surgery The Post-Aprotinin Era
    DeSantis, Stacia M.
    Toole, J. Matthew
    Kratz, John M.
    Uber, Walter E.
    Wheat, Margaret J.
    Stroud, Martha R.
    Ikonomidis, John S.
    Spinale, Francis G.
    CIRCULATION, 2011, 124 (11) : S62 - S69
  • [37] Transfusion requirements, morbidity and mortality in cardiac surgery and the use of antifibrinolytic agents: a comparison of aprotinin and tranexamic acid
    Muedra, V.
    Delas, F.
    Villalonga, V.
    Gomez, M.
    Sanchez, F.
    Llopis, J. E.
    REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2011, 58 (03): : 140 - 146
  • [38] HIGH-DOSE APROTININ IN CARDIAC-SURGERY - A PROSPECTIVE, RANDOMIZED STUDY
    SWART, MJ
    GORDON, PC
    HAYSEGREGSON, PB
    DYER, RA
    SWANEPOEL, AL
    BUCKELS, NJ
    SCHALL, R
    ODELL, JA
    ANAESTHESIA AND INTENSIVE CARE, 1994, 22 (05) : 529 - 533
  • [39] Aprotinin and transfusion requirements in pediatric craniofacial surgery
    Ahmed, Zulfiqar
    Stricker, Lori
    Rozzelle, Arlene
    Zestos, Maria
    PEDIATRIC ANESTHESIA, 2014, 24 (02) : 141 - 145
  • [40] Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study
    Jakobsen, Carl-Johan
    Sondergaard, Flemming
    Hjortdal, Vibeke E.
    Johnsen, Soren P.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 36 (05) : 863 - 868
12345